The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3,4-dimethoxyphenethyl)-4-(2-ethoxyphenyl)piperazine ID: ALA3902626
Cas Number: 1248-54-0
PubChem CID: 121102
Max Phase: Preclinical
Molecular Formula: C22H30N2O3
Molecular Weight: 370.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1ccccc1N1CCN(CCc2ccc(OC)c(OC)c2)CC1
Standard InChI: InChI=1S/C22H30N2O3/c1-4-27-20-8-6-5-7-19(20)24-15-13-23(14-16-24)12-11-18-9-10-21(25-2)22(17-18)26-3/h5-10,17H,4,11-16H2,1-3H3
Standard InChI Key: NSQCHSZFXOYJID-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
22.5606 -7.6629 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2775 -8.0618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9786 -7.6437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9669 -6.8266 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2541 -6.4276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5530 -6.8458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6721 -6.4085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3849 -6.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0860 -6.3894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0743 -5.5723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3615 -5.1733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6604 -5.5914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3925 -7.6246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.1052 -8.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8595 -8.0810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1467 -7.6820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0276 -8.1151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0393 -8.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7521 -9.3353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4573 -8.9172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4456 -8.1001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7328 -7.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8075 -7.6056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3372 -9.3454 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3467 -10.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3186 -7.7128 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6153 -8.1290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
13 14 1 0
8 13 1 0
4 7 1 0
15 16 1 0
17 18 1 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
18 19 2 0
16 21 1 0
1 15 1 0
14 23 1 0
24 25 1 0
18 24 1 0
26 27 1 0
17 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 370.49Molecular Weight (Monoisotopic): 370.2256AlogP: 3.47#Rotatable Bonds: 8Polar Surface Area: 34.17Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.67CX LogP: 3.83CX LogD: 3.37Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.71Np Likeness Score: -1.04
References 1. Silva RO, de Oliveira AS, Nunes Lemes LF, de Camargo Nascente L, Coelho do Nascimento Nogueira P, Silveira ER, Brand GD, Vistoli G, Cilia A, Poggesi E, Buccioni M, Marucci G, Bolognesi ML, Romeiro LAS.. (2016) Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor., 122 [PMID:27448917 ] [10.1016/j.ejmech.2016.06.052 ]